Efficient production and characterization of Bacillus anthracis lethal factor and a novel inactive mutant rLFm-Y236F

Protein Expression and Purification

Volumn 59, Issue 1, 2008, Pages 25-30

  Cao, Sha ^a   Liu, Ziduo ^a   Guo, Aizhen ^a   Li, Yan ^a   Zhang, Chengxian ^a   Gaobing, Wu ^a   Chunfang, Feng ^a   Tan, Yadi ^a   Chen, Huanchun ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Anthrax; Bacillus anthracis; Lethal factor; Lethal toxin; Protein purification

Indexed keywords

ANTHRAX TOXIN; BACTERIAL ANTIGEN; BACTERIAL TOXIN; METALLOPROTEINASE;

ANIMAL; ARTICLE; BACILLUS ANTHRACIS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR CLONING; MOUSE; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ANIMALS; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CELL SURVIVAL; CLONING, MOLECULAR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; METALLOENDOPEPTIDASES; MICE;

BACILLUS ANTHRACIS; ESCHERICHIA COLI; MUS;

EID: 40849102523     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.12.013     Document Type: Article

References (25)

1. Artenstein A.W., Opal S.M., Cristofaro P., Palardy J.E., Parejo N.A., Green M.D., and Jhung J.W. Chloroquine enhances survival in Bacillus anthracis intoxication. J. Infect. Dis. 190 (2004) 1655-1660
2. Mock M., and Fouet A. Anthrax. Annu. Rev. Microbiol. 55 (2001) 647-671
3. Young J.A., and Collier R.J. Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu. Rev. Biochem. 76 (2007) 243-265
4. Brossier F., Sirard J.C., Guidi-Rontani C., Duflot E., and Mock M. Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen. Infect. Immun. 67 (1999) 964-967
5. Olsnes S., Kozlov J.V., van Deurs B., and Sandvig K. Bacterial protein toxins acting on intracellular targets. Semin. Cell Biol. 2 (1991) 7-14
6. Gupta P., Waheed S.M., and Bhatnagar R. Expression and purification of the recombinant protective antigen of Bacillus anthracis. Protein Expr. Purif. 16 (1999) 369-376
7. Chvyrkova I., Zhang X.C., and Terzyan S. Lethal factor of anthrax toxin binds monomeric form of protective antigen. Biochem. Biophys. Res. Commun. 360 (2007) 690-695
8. Scobie H.M., and Young J.A. Interactions between anthrax toxin receptors and protective antigen. Curr. Opin. Microbiol. 8 (2005) 106-112
9. Gaddis B.D., Avramova L.V., and Chmielewski J. Inhibitors of anthrax lethal factor. Bioorg. Med. Chem. Lett. 17 (2007) 4575-4578
10. Cui X., Li Y., Moayeri M., Choi G.H., Subramanian G.M., Li X., Haley M., Fitz Y., Feng J., Banks S.M., Leppla S.H., and Eichacker P.Q. Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis. J. Infect. Dis. 191 (2005) 422-434
11. Rhie G.E., Park Y.M., Han J.S., Yu J.Y., Seong W.K., and Oh H.B. Efficacy of non-toxic deletion mutants of protective antigen from Bacillus anthracis. FEMS Immunol. Med. Microbiol. 45 (2005) 341-347
12. Mourez M., Yan M., Lacy D.B., Dillon L., Bentsen L., Marpoe A., Maurin C., Hotze E., Wigelsworth D., Pimental R.A., Ballard J.D., Collier R.J., and Tweten R.K. Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis. Proc. Natl. Acad. Sci. USA 100 (2003) 13803-13808
13. Liang X., Young J.J., Boone S.A., Waugh D.S., and Duesbery N.S. Involvement of domain II in toxicity of anthrax lethal factor. J. Biol. Chem. 279 (2004) 52473-52478
14. Pezard C., Berche P., and Mock M. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 59 (1991) 3472-3477
15. Sanchez A.M., and Bradley K.A. Anthrax toxin: can a little be a good thing?. Trends Microbiol. 12 (2004) 143-145
16. Shoop W.L., Xiong Y., Wiltsie J., Woods A., Guo J., Pivnichny J.V., Felcetto T., Michael B.F., Bansal A., Cummings R.T., Cunningham B.R., Friedlander A.M., Douglas C.M., Patel S.B., Wisniewski D., Scapin G., Salowe S.P., Zaller D.M., Chapman K.T., Scolnick E.M., Schmatz D.M., Bartizal K., MacCoss M., and Hermes J.D. Anthrax lethal factor inhibition. Proc. Natl. Acad Sci. USA 102 (2005) 7958-7963
17. Leppla S.H. Production and purification of anthrax toxin. Methods Enzymol. 165 (1988) 103-116
18. Park S., and Leppla S.H. Optimized production and purification of Bacillus anthracis lethal factor. Protein Expr. Purif. 18 (2000) 293-302
19. Chang H.H., Tsai M.F., Chung C.P., Chen P.K., Hu H.I., Kau J.H., Huang H.H., Lin H.C., and Sun D.S. Single-step purification of recombinant anthrax lethal factor from periplasm of Escherichia coli. J. Biotechnol. 126 (2006) 277-285
20. Kim J., Kim Y.M., Koo B.S., Chae Y.K., and Yoon M.Y. Production and proteolytic assay of lethal factor from Bacillus anthracis. Protein Expr. Purif. 30 (2003) 293-300
21. Peachman K.K., Rao M., Alving C.R., Burge R., Leppla S.H., Rao V.B., and Matyas G.R. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen. Infect Immun. 74 (2006) 794-797
22. Price B.M., Liner A.L., Park S., Leppla S.H., Mateczun A., and Galloway D.R. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein. Infect. Immun. 69 (2001) 4509-4515
23. Tan Y., Hackett N.R., Boyer J.L., and Crystal R.G. Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen. Hum. Gene Ther. 14 (2003) 1673-1682
24. Maliandi M.V., Busi M.V., Clemente M., Zabaleta E.J., Araya A., and Gomez-Casati D.F. Expression and one-step purification of recombinant Arabidopsis thaliana frataxin homolog (AtFH). Protein Expr. Purif. 51 (2007) 157-161
25. Lacy D.B., Mourez M., Fouassier A., and Collier R.J. Mapping the anthrax protective antigen binding site on the lethal and edema factors. J. Biol. Chem. 277 (2002) 3006-3010